Screener
Evommune EVMN Q2 2026 earnings
Reported August 6, 2026 · After market close
EPS-$0.89Miss by $0.23
Revenue estimate$1.3M
EPS estimate-$0.66
Next report
Oct 16, 2026 (in 2 months)Revenue estimate$500.0K
EPS estimate-$0.82
Versus estimates
Revenue
Diluted EPS
Q2 2026-$0.89Miss by $0.23
Q1 2026-$0.64Beat by $0.19Q4 2025-$1.43Miss by $0.61Q3 2025-$8.07Miss by $1.99FAQ
- When did Evommune report Q2 2026 earnings?
- Evommune (EVMN) reported Q2 2026 earnings on August 6, 2026 after market close.
- What were Evommune's Q2 2026 revenue and EPS?
- Evommune reported eps of $-0.89 for Q2 2026.
- Did Evommune beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.66 by $0.23.
- Where can I find Evommune's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-337964) and the 10-Q periodic report (0001193125-26-337984) directly on SEC EDGAR. The filing index links above go to sec.gov.
